...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Child and adolescent psychiatric clinics of North America >Psychopharmacologic Management of Serious Behavioral Disturbance in ASD
【24h】

Psychopharmacologic Management of Serious Behavioral Disturbance in ASD

机译：自闭症严重行为障碍的心理药物管理

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Individuals diagnosed with autism spectrum disorders (ASD) often exhibit serious behavioral disturbance (irritability) including severe tantrums, aggression, and self-injury that requires pharmacologic management. Research focused on the treatment of severe irritability has primarily involved the atypical antipsychotics, including risperidone and aripiprazole. Anticonvulsants have also been investigated for targeting serious behavioral disturbance; however findings have been mixed. Advances in the pharmacotherapy of irritability in ASD continue to inform practice. Research is needed to develop safer and more effective drug treatments for serious behavioral disturbance in this population.
机译：被诊断患有自闭症谱系障碍（ASD）的个体通常表现出严重的行为障碍（易怒），包括严重的发脾气，攻击性和需要药理管理的自我伤害。专注于严重易怒性治疗的研究主要涉及非典型抗精神病药，包括利培酮和阿立哌唑。抗惊厥药也已针对严重的行为障碍进行了研究。但是，结果好坏参半。 ASD易怒性药物治疗的进展继续为实践提供信息。需要进行研究以开发更安全，更有效的药物治疗该人群的严重行为障碍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号